The Siam Cement Public Company Limited
The Siam Cement Public Company Limited (SCVUF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for The Siam Cement Public Company Limited (SCVUF), covering cash flow, earnings, and balance sheets.
The Siam Cement Public Company Limited (SCVUF) Income Statement & Financial Overview
Explore comprehensive income reports for The Siam Cement Public Company Limited SCVUF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $124.39B | $130.51B | $128.20B | $128.20B |
| Cost of Revenue | $106.10B | $115.74B | $113.75B | $109.22B |
| Gross Profit | $18.29B | $14.77B | $14.45B | $18.98B |
| Gross Profit Ratio | $0.15 | $0.11 | $0.11 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $16.78B | $12.63B | $16.32B | $17.18B |
| Operating Expenses | $14.83B | $13.69B | $12.62B | $17.18B |
| Total Costs & Expenses | $120.93B | $129.43B | $126.37B | $126.40B |
| Interest Income | $0.00 | $1.94B | $0.00 | $0.00 |
| Interest Expense | $2.83B | $3.18B | $2.82B | $2.88B |
| Depreciation & Amortization | $8.29B | $8.56B | $7.71B | $7.69B |
| EBITDA | $13.18B | $10.83B | $10.80B | $9.49B |
| EBITDA Ratio | $0.11 | $0.08 | $0.08 | $0.07 |
| Operating Income | $3.46B | $1.08B | $1.83B | $1.80B |
| Operating Income Ratio | $0.03 | $0.008 | $0.01 | $0.01 |
| Other Income/Expenses (Net) | -$1.40B | -$2.00B | -$2.82B | $205.53M |
| Income Before Tax | $2.06B | -$914.56M | -$991.07M | $2.004B |
| Income Before Tax Ratio | $0.02 | -$0.007 | -$0.008 | $0.02 |
| Income Tax Expense | $1.20B | $433.59M | $758.42M | $1.19B |
| Net Income | $1.10B | -$512.44M | $721.29M | $3.71B |
| Net Income Ratio | $0.009 | -$0.004 | $0.006 | $0.03 |
| EPS | $0.92 | -$0.43 | $0.60 | $3.09 |
| Diluted EPS | $0.92 | -$0.43 | $0.60 | $3.09 |
| Weighted Avg Shares Outstanding | $1.19B | $1.20B | $1.20B | $1.20B |
| Weighted Avg Shares Outstanding (Diluted) | $1.19B | $1.20B | $1.20B | $1.20B |
The company's financials show resilient growth, with revenue advancing from $128.20B in Q2 2024 to $124.39B in Q1 2025. Gross profit remained healthy with margins at 15% in Q1 2025 compared to 15% in Q2 2024. Operating income hit $3.46B last quarter, sustaining a consistent 3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $13.18B. Net income rose to $1.10B, while earnings per share reached $0.92. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan